1 The effects of yohimbine (0.5mg kg-i.v.) on both resting and parasympathetic and sympathetic stimulation-induced submaxillary salivary responses were investigated in the anaesthetized dog. 2 Salivary secretion was increased significantly for a period of 45min following an injection of yohimbine. 3 Sectioning of the chorda tympani (but not the cervical sympathetic) nerve abolished the yohimbine-induced increase in resting salivary secretion and potentiated that elicited by electrical stimulation of the chorda tympani nerve. 4 These results show that yohimbine increases submaxillary secretion by inhibition of presynaptic a2-adrenoceptors located on the chorda tympani, which inhibit cholinergic transmission.
Introduction
Several experiments have suggested the involvement of postsynaptic a2-adrenoceptors in the control of sympathetically and parasympathetically-mediated salivation in the rat (Bylund & Martinez, 1980; 1981; Martinez et al., 1982; Elverdin et al., 1984) . In fact, a common side-effect of treatment with a2-adrenoceptor agonists, especially clonidine, is reduced salivation and a dry mouth. Clonidine reduced submaxillary salivation provoked by either brainstem or peripheral nerve stimulation (Green et al., 1979a) ; guanabenz, another o2-adrenoceptor agonist antagonized the secretory responses to noradrenaline, methacholine, substance P (Kaniucki et al., 1984; 1985) and to electrical stimulation of the chorda tympani (Terzic & Stojic, 1986) . The decrease in salivation induced by guanabenz was virtually abolished by yohimbine, but not by the a1-adrenoceptor antagonist prazosin (Terzic & Stojic, 1986) . The effects of a2-adrenoceptor antagonists on salivary secretion, in contrast, have been poorly investigated. Thus, the aim of the present study was to investigate the effects of yohimbine, an a2-adrenoceptor antagonist (Goldberg & Robertson, 1983) on both resting salivation and that produced in response to parasympathetic and sympathetic nerve stimulation in the anaesthetized dog. ' Author for correspondence.
Methods
Animals and general procedure Dogs of either sex (7 to 15kg) were anaesthetized with a mixture of chloralose (40mg kg-1 i.v.) plus urethane (500mg kg-1 i.v.). This combination of anaesthetics was chosen from information obtained in preliminary experiments (not shown) which indicated that under either chloralose or, urethane or sodium thiopentone anaesthesia, yohimbine remained ineffective. In view of the potential a2-adrenoceptor antagonist properties of urethane (Armstrong et al., 1982; Langer & Shepperson, 1982; Moore et al., 1984) Experiment 1: Effect of yohimbine on spontaneous submaxillary salivation Yohimbine (0.5mg kg-1 i.v., 3 ml, n = 6) and saline (0.9% NaCl 3 ml, in sham experiments, n = 6) were each injected after dissection had been completed, after at least 30 min in resting conditions and salivary secretion from both submaxillary ducts collected every 15 min thereafter for a period of 90 min.
Experiment 2: Effect ofyohimbine on parasympathetic salivation A group of experiments (2a, n = 6) was performed in order to intestigate the effect of yohimbine on spontaneous salivation with and without the chorda tympani nerve being sectioned. The left chorda tympani nerve was then cut and the effects of yohimbine (0.5 mg kg-1 i.v.) on the spontaneous salivation from the intact (right) side compared with the values obtained on the sectioned (left) side.
A second group of experiments (2b) investigated the effect of yohimbine on electrically-induced parasympathetic salivation. After dissection, the left chorda tympani was cut, immersed in a pool of paraffin oil (38°C) and the peripheral end stimulated via bipolar stainless steel electrodes (15 s trains, supramaximal intensity, O.ims, 10Hz every 15min, once before and six times after yohimbine (or saline) administration). These parameters of stimulation were chosen since they mimic the salivary secretion found with an intact nerve. Saliva was collected during these 15s periods of stimulation and during the 15 min period following stimulation. The effects of saline (3 ml, i.v., n = 6) and yohimbine (0.5 mg kg-1 3 ml, i.v., n = 6) injected at time 0 (i.e. at least 30min after dissection) were compared on the output of saliva produced by stimulation of the chorda tympani nerve.
Experiment 3: Effect of yohimbine on sympathetic salivation In 6 other dogs, the left cervical sympathetic nerve was cut in the vagal sympathetic trunk and the effects of yohimbine (0.5 mg kg-1 i.v.) on the intact (right) side compared with the values obtained on the sectioned and stimulated side according to the protocol described in experiment 2b (15 s trains, supramaximal intensity, 0.1Ims, 10 Hz every 15 min, once before and six times after yohimbine or saline (3 ml) administration).
Drug administration
Yohimbine hydrochloride (Sigma), dissolved in 3 ml saline (0.9%) was injected via the saphenous vein.
The dose (0.5mgkg-') antagonized the depressor effects of 104gkg-i.v. clonidine on blood pressure, metabolism (plasma free fatty acids and glycerol) and submaxillary salivation (Taouis et al., 1988) . Controls received 3 ml saline i.v. as a sham injection.
Statistical analysis
Results are presented as mean values + s.e.mean. Significance was estimated by use of Student's t test (after one-way analysis of variance). Student's t test for paired comparisons was used when intact and sectioned sides were compared. P values less than 0.05 were considered significant.
Results
Experiment 1:-effect ofyohimbine on spontaneous submaxillary salivation (Figure 1) Compared with saline, yohimbine significantly increased salivary secretion during the 45 min following injection. After this time, due to the large individual variations, the increase was not significant. Yohimbine failed to modify blood pressure or heart rate (not shown) eliminating any possibility that variation in salivation arose from changes in blood pressure. 
Discussion
Yohimbine induced a significant increase in the spontaneous salivary secretion in the submaxillary gland of the dog. The effect of yohimbine lasted for 45 min: this duration of action compares with a halflife in man of around 0.6 h (Owen et al., 1987) . This stimulating effect of yohimbine, an a2-adrenoceptor Figure 4 The effect of nerve section on the ability of yohimbine (0.5mgkg-' i.v. at This effect of yohimbine is dependent on the integrity of the parasympathetic innervation. Thus (1) it is suppressed by sectioning of the cholinergic chorda tympani nerve while (2) yohimbine itself potentiated the increase in salivary secretion in response to chorda tympani stimulation. In contrast, yohimbine did not modify the salivary volume obtained in response to sympathetic nerve stimulation while prior sectioning of the superior cervical sympathetic nerve did not change the magnitude of yohimbineinduced salivation. These results and those of Green et al. (1979a) suggest that a2-adrenoceptors may regulate cholinergic (but not sympathetic) transmission and that yohimbine increases submaxillary secretion by inhibition of presynaptic a2-adrenoceptors (located on the chorda tympani) which inhibit cholinergic transmission. The role of presynaptic U2-adrenoceptors in the control of acetylcholine release has been well documented (Langer, 1977) . In fact, an effect of yohimbine on postsynaptic inhibitory a2-adrenoceptors located on the submaxillary gland can be ruled out since yohimbine failed to induce salivary secretion after section of the chorda tympani.
The effect of yohimbine could also have a central component which we cannot evaluate. The central effect is probably of importance since Green et al. (1979b) found that clonidine reduces submaxillary salivation evoked by brainstem stimulation in cats. However, the finding that yohimbine remained active during stimulation of the distal end of the chorda tympani (at a frequency which mimicked the salivary secretion found when the nerve was intact) suggests a peripheral action of yohimbine on the x2-adrenoceptors located on the parasympathetic nerve endings.
